Jeff Bird is a seasoned professional in the investment and healthcare sectors, currently serving as Managing Director at Bluebird Ventures since August 2019 and holding a dual role as Limited Partner and Managing Director at Sutter Hill Ventures since June 2002. Bird is an active investor and board member for various health-related companies, including Stanford Health Care, Leyden Labs, Foresight Dx, Kriya Therapeutics, Nutcracker Therapeutics, Epirium, and Procyrion, Inc. With an extensive educational background, Bird holds an MD and Ph.D. in Cancer Biology from Stanford University School of Medicine and a Bachelor of Science from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices